Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052783

President sold 94,725 shares at $49.00 ($4,641,525)

  • President acquired 94,725 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-29 Exercise or conversion : show line 1 in the form +80,000 $0.84 $67,200 80,000 D
2020-09-29 Sale : show line 2 in the form −80,000 $49.00 $3,920,000 0 D
2020-10-01 Exercise or conversion : show line 3 in the form +14,725 $0.84 $12,369 14,725 D
2020-10-01 Sale : show line 4 in the form −14,725 $49.00 $721,525 0 D
Open-market sales · 94,725 sh · avg $49.00 · $4,641,525

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-09-29 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −80,000 14,725 D
2020-10-01 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −14,725 0 D
Loading xslF345X03/doc4.xml…